Item


Hipertensión arterial y enfermedad de Alzheimer

Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studies

© Alzheimer. Realidades e investigación en demencia, 2010, núm. 45, p. 30-39

Editorial Glosa

Author: Coll de Tuero, Gabriel
Date: 2010
Abstract: Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studies
Format: application/pdf
ISSN: 1137-1242
Document access: http://hdl.handle.net/10256/7541
Language: eng
Publisher: Editorial Glosa
Collection: Articles publicats (D-CM)
Is part of: © Alzheimer. Realidades e investigación en demencia, 2010, núm. 45, p. 30-39
Rights: Tots els drets reservats
Subject: Hipertensió
Hypertension
Alzheimer, Malaltia d’ -- Tractament
Alzheimer’s disease -- Treatment
Title: Hipertensión arterial y enfermedad de Alzheimer
Type: info:eu-repo/semantics/article
Repository: DUGiDocs

Subjects

Authors